Search Results - taia+wang

3 Results Sort By:
­MEASUREMENT OF AFUCOSYLATED IgG Fc GLYCANS TO PREDICT RISK OF SEVERE COVID-19 DISEASE
­MEASUREMENT OF AFUCOSYLATED IgG Fc GLYCANS TO PREDICT RISK OF SEVERE COVID-19 DISEASE Researchers at Stanford have developed a method for identifying a subject that is at risk of progression to clinically significant COVID-19 infection or disease. A minority of individuals infected with SARS-CoV-2 mount an extreme inflammatory response that...
Published: 3/17/2023   |   Inventor(s): Taia Wang
Keywords(s): Afucosylation, Antibody, COVID-19, Glycoform, Glycosylation, IgG, Non-Neutralizing, Receptor, Symptom, Vaccine
Category(s): Technology Classifications > Biology
AFUCOSYLATED MATERNAL ANTI-DENGUE IGGS ARE A BIOMARKER FOR SUSCEPTIBILITY TO SEVERE DENGUE DISEASE IN INFANTS
AFUCOSYLATED MATERNAL ANTI-DENGUE IGGS ARE A BIOMARKER FOR SUSCEPTIBILITY TO SEVERE DENGUE DISEASE IN INFANTS Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed a method for determining infant susceptibility to severe dengue disease through measurement of maternal anti-dengue IgG. Mortality rates in severe dengue...
Published: 3/17/2023   |   Inventor(s): Taia Wang
Keywords(s): Afucosylation, Antibody, Dengue, Fc Domain, Glycosylation, IgG
Category(s): Technology Classifications > Biology
Monoclonal Antibodies Against Influenza Virus Generated By Cyclical Administration
Thank you for your interest in this technology. Please see our technology brief here: https://app.in-part.com/articles/ekxNm4PG7bom
Published: 10/23/2024   |   Inventor(s): Peter Palese, Taia Wang, Adolfo Garcia-Sastre
Keywords(s): Infectious Disease
Category(s): Therapeutic